INTRAVITREAL TRIAMCINOLONE NOT EFFECTIVE IN DIABETIC MACULAR EDEMA?

OSN SuperSite - The Voice of Ophthalmology - latest news and articles from Ocular Surgery News; Ophthalmic Surgery, Lasers and Imaging; Journal of Refractive Surgery; and Pediatric Ophthalmology and Strabismus This report stated: "Patients treated with intravitreal triamcinolone or a laser for persistent diabetic macular edema showed “no statistically significant improvement from baseline” at the 1–year follow-up, said Zdenek Gregor, MD, at the French Society of Ophthalmology meeting.

"Patients experienced an initial improvement in best corrected visual acuity and a reduction of macular thickness. However, by 1 year, results returned to near baseline and there was no statistically significant improvement in either group, he said.

"'The results were inconclusive or rather negative. Intravitreal triamcinolone up to 1 year did not improve BCVA, did not reduce macular thickness or volume' Dr. Gregor said. 'Intravitreal triamcinolone is unlikely to improve visual acuity in any lasting fashion.'"

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH